Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings Call Transcript
…
1,179$
-0,13%
Echtzeit-Aktienkurs Co-Diagnostics Inc.
Bid:
Ask:
Nachrichten zur Co-Diagnostics Inc. Aktie
Global Nanofiber Materials For Biomedical Market Size To worth USD 18184.90 Million By 2033 | CAGR of 24.80%
The Global Nanofiber Materials For Biomedical Market Size was Valued at USD 1984.90 Million in 2023 and the Worldwide Nanofiber…
Co-Diagnostics, Inc. (CODX) Q2 2024 Earnings Call Transcript
…
Co-Diagnostics, Inc. (CODX) Q1 2024 Earnings Call Transcript
…
Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript
…
Co-Diagnostics applies for FDA okay of COVID-19 test, stock rallies 17%
…
Plasmonic Materials Market Q4 2023 Exclusive Report with Accurate Forecast to 2031
Companies covered in this report are Nanopartz Inc., Nanocomposix Inc., Plasmonic Biosensors Inc., Nanospectra Biosciences Inc., Nanostructured and Amorphous Materials…
Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings Call Transcript
…
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Lags Revenue Estimates
Co-Diagnostics, Inc. (CODX) delivered earnings and revenue surprises of -29.17% and 73.60%, respectively, for the quarter ended June 2023. Do…
Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results
Co-Dx receives grant awards from the Bill & Melinda Gates Foundation; NIH RADx® Tech to develop tests on our new…
Form 8-K Co-Diagnostics, Inc. For: Aug 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Co-Diagnostics, Inc. Announces Second Quarter 2023 Earnings Release Date and Webcast
SALT LAKE CITY, July 27, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented…
Form 8-K Co-Diagnostics, Inc. For: May 12
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-Q Co-Diagnostics, Inc. For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Co-Diagnostics, Inc. Reports First Quarter 2023 Financial Results
Clinical trials for Co-Dx PCR Home™ platform remain on track; Solid cash position and grant funding support long-term strategy SALT…
Co-Diagnostics, Inc. Announces First Quarter 2023 Earnings Release Date and Webcast
SALT LAKE CITY, May 5, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented…
Form 8-K Co-Diagnostics, Inc. For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Financial Officer kauft Aktien von Co-Diagnostics im Wert von 5.697$
Brown, Brian Lee - Vorstand - Tag der Transaktion: 2023-03-20...…
Co-Diagnostics, Inc. to CEO to Deliver Keynote Address at 2023 MarketsandMarkets Conference in London, England
SALT LAKE CITY, March 21, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…
Co-Diagnostics hits 52-week low as H.C. Wainwright cuts rating
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-K Co-Diagnostics, Inc. For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Co-Diagnostics FY 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 EARNINGS RELEASE DATE AND WEBCAST
SALT LAKE CITY, March 9, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented…
Co-Diagnostics, Inc. Initiates Clinical Evaluations for its At-Home and Point-of-Care Co-Dx PCR Home™ Platform
SALT LAKE CITY, Feb. 22, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Co-Diagnostics, Inc.
Wilmington, Delaware--(Newsfile Corp. - February 7, 2023) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors…
Co-Diagnostics, Inc. Commemorates Third Anniversary of the Completion of its First COVID-19 Test Design
Designed using the Companys proprietary platform, initial test design remains effective detection tool even after three years of variants and…
Co-Diagnostics, Inc. to Host Booth at CES 2023 January 5-8
SALT LAKE CITY, Jan. 5, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…
Digital pathology market to grow by 13.1% Y-O-Y from 2022 to 2023: Growing adoption of IoT infrastructure among laboratories will drive growth -Technavio
NEW YORK, Dec. 14, 2022 /PRNewswire/ -- Digital Pathology Market Insights - Vendors: 15+, 3DHISTECH Ltd., Apollo Enterprise Imaging Corp.,…
Co-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022
SALT LAKE CITY, Nov. 30, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…
Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany
SALT LAKE CITY, Nov. 14, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…
Form 10-Q Co-Diagnostics, Inc. For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Co-Diagnostics Q3 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Co-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ
SALT LAKE CITY, Nov. 3, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…
Co-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer
SALT LAKE CITY, Nov. 1, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company…
CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST
SALT LAKE CITY, Oct. 27, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented…
Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa
SALT LAKE CITY, Oct. 26, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Co-Diagnostics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NASDAQ: CODX)
NEW YORK, Oct. 19, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Co-Diagnostics, Inc..…
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Co-Diagnostics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, Oct. 17, 2022 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of…
CODX FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - CODX
NEW YORK, Oct. 14, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
CODX SHAREHOLDER ALERT: Jakubowitz Law Reminds Co-Dx Shareholders of a Lead Plaintiff Deadline of October 17, 2022
NEW YORK, Oct. 14, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Co-Diagnostics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NASDAQ: CODX)
NEW YORK, Oct. 12, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Co-Diagnostics, Inc..…
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - CODX
NEW YORK, Oct. 11, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics,…
CODX SHAREHOLDER ALERT: Jakubowitz Law Reminds Co-Dx Shareholders of a Lead Plaintiff Deadline of October 17, 2022
NEW YORK, Oct. 7, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…
CODX LAWSUIT ALERT: Levi & Korsinsky Notifies Co-Diagnostics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 6, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Co-Diagnostics, Inc. ("Co-Dx" or the "Company")…
CODX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on Behalf of Co-Diagnostics, Inc. Shareholders
NEW YORK, Oct. 4, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - CODX
NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics,…
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Co-Dx Investors of a Lead Plaintiff Deadline of October 17, 2022
NEW YORK, Oct. 3, 2022 /PRNewswire/ -- Attention Co-Diagnostics, Inc. ("Co-Dx") (NASDAQ: CODX) shareholders: The Law Offices of Vincent Wong…